Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients
    Meeting Abstract

    Bao, T.; Seidman, A. D.; Piulson, L.; Chen, X.; Vickers, A. J.; Vertosick, E.; Blinder, V. S.; Zhi, W. I.; Li, Q. S.; Vahdat, L. T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Impact of prior systemic therapy on lymphocytic infiltration in surgically resected breast cancer brain metastases
    Meeting Abstract

    Bacotti, A.; Wang, R.; Deal, A. M.; Prince, G.; McKee, M. J.; Moschos, S. J.; Brogi, E.; Morikawa, A.; Anders, C. K.; Seidman, A. D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Survival outcome of breast cancer (BC) patients presenting with recurrent and de novo isolated contralateral lymph node metastases (CLNM)
    Meeting Abstract

    Al-Awadhi, A.; Lei, X.; Sanford, R. A.; Valero, V.; Giordano, S. H.; Chavez-MacGregor, M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    McBride, S. M.; Sherman, E. J.; Tsai, C. J.; Baxi, S. S.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D. C.; Michel, L. S.; Spielsinger, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A single-arm, phase II study assessing the efficacy of pembrolizumab (pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC)
    Meeting Abstract

    McArthur, H. L.; Barker, C. A.; Gucalp, A.; Lebron-Zapata, L.; Wen, Y. H.; Phung, A.; Rodine, M.; Arnold, B.; Zhang, Z.; Ho, A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The CHANCE study: A prospective, longitudinal study of chemotherapy and hormonal therapy induced hair changes and alopecia, skin aging and nail changes in women with non-metastatic breast cancer
    Meeting Abstract

    Lacouture, M. E.; Freites-Martinez, A.; Patil, S.; Samuels, A.; Shapiro, J.; Ciccolini, K.; Kukoyi, O.; Goldfarb, S. B.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Selecting patients with triple negative breast cancer for platinum-based therapy: We still haven't found what we're looking for
    Journal Article

    Robson, M.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Estimation of tumor-derived mutant allele fractions in cfDNA by shallow whole genome sequencing and fragment size analysis
    Meeting Abstract

    Yang, J.; Marass, F.; Ulz, P.; Shady, M.; Cheng, M. L.; Kothari, P.; Gedvilaite, E.; Somnay, S.; Shukla, N.; Modak, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • OlympiAD final overall survival: Olaparib versus chemotherapy treatment of physician's choice (TPC) in patients with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm)
    Meeting Abstract

    Robson, M. E.; Im, S. A.; Senkus, E.; Xu, B.; Domchek, S.; Masuda, N.; Delaloge, S.; Li, W.; Tung, N.; Armstrong, A.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • A phase I basket study of the PI3K inhibitor taselisib (GDC-0032) in PIK3CA-mutated locally advanced or metastatic solid tumors
    Meeting Abstract

    Jhaveri, K.; Juric, D.; Saura, C.; Cervantes, A.; Melnyk, A.; Patel, M. R.; Oliveira, M.; Gambardella, V.; Ribrag, V.; Ma, C. X.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save